Brain Tumor Treatments: Texas
Sponsored By
Tocagen trial
Please Click On The Above Banner For More Details
Braintumor Website

Major Brain Tumor Centers

(This is not a complete listing - see this page for details)
TX: Amarillo Texas Tech University Health Sciences Center School of Medicine
TX: Corpus Christi Cancer Specialists of South Texas
TX: Dallas Baylor
TX: Dallas Baylor University Medical Center at Dallas
TX: Dallas Children`s Medical Center of Dallas
TX: Dallas Medical City Dallas Hospital
TX: Dallas Simmons Cancer Center at University of Texas Southwestern Medical Center - Dallas
TX: Dallas Simmons Comprehensive Cancer Center
TX: Dallas Texas Cancer Center at Medical City Dallas Hospital
TX: Dallas U. of Texas Southwestern Medical Center at Dallas
TX: Dallas U. Of Texas Southwestern Medical School
TX: Fort Worth Medical City Dallas Hospital *
TX: Galveston University of Texas Medical Branch
TX: Houson University of Texas, MD Anderson Cancer Center
TX: Houston Baylor College of Medicine
TX: Houston M.D. Anderson Cancer Center
Tx: Houston M.D. Anderson Cancer Center at University of Texas
TX: Houston MD Anderson Cancer Center
TX: Houston MD Andreson Cancer Center
TX: Houston Methodist Hospital
TX: Houston Methodist Neurological Institute
TX: Houston Texas Children`s Cancer Center and Hematology Service at Texas Children`s Hospital
TX: Houston Texas Children`s Cancer Center, Baylor College of Medicine
TX: Houston Texas Childrens Cancer Center
TX: Houston The Methodist Hospital *
TX: Houston The University of Texas Health Science Center at Houston
TX: Houston University of Texas M.D. Anderson Cancer Center
TX: San Antonio MBCCOP - South Texas Pediatrics
TX: San Antonio Methodist Cancer Center
TX: San Antonio Methodist Cancer Center at Methodist Specialty and Transplant Hospital
TX: San Antonio U. of Texas at San Antonio
TX: San Antonio U. Of Texas Health Science Center At San Antonio
TX: San Antonio University of Texas Health Science Center at San Antonio
Search Term: Texas
  Previous 25 Showing Treatment 26 to 50 of 95 Next 25 Location Last Updated
Details Phase II Trial of Chemotherapy with Temozolomide in Combination with Topotecan for Central Nervous System (CNS) Metastases of Solid Tumors Houston, TX USA 12/20/2010
Details A Phase 2a Study of AdV-tk + Valacyclovir Gene Therapy in Combination With Standard Radiation Therapy for Malignant Glioma Houston, TX USA 12/20/2010
Details A Phase 1b Study of AdV-tk + Valacyclovir Gene Therapy in Combination With Standard Radiation Therapy for Malignant Gliomas Houston, TX USA 12/20/2010
Details A Phase II Study of Gliadel, Concomitant Temozolomide and Radiation, followed by Dose Dense Therapy with Temozolomide Plus Bevacizumab (Avastin) for Newly Diagnosed Malignant High Grade Gliomas Houston, TX USA 12/20/2010
Details RTOG 0825 Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab versus Conventional Concurrent Houston, TX USA 12/20/2010
Details BTTC08-01: Phase II Post-RT/TMZ Bevacizumab and Erlotinib for newly GBM without MGMT promoter methylation Houston, TX USA 12/20/2010
Details Meningioma: Risk Factors and Quality of Life Houston, TX USA 12/20/2010
Details Evaluating the Feasibility of Real-Time, Magnetic Resonance Thermal Imaging and Magnetic Resonance Imaging (MRI)-Guided Laser Induced Thermal Therapy (LITT) for the Treatment of Metastatic Brain Tumors Houston, TX USA 12/20/2010
Details Molecular Biology of Central Nervous System (CNS) Tumors Houston, TX USA 12/20/2010
Details Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter Status (CORE) Dallas, TX USA 11/12/2010
Details Bevacizumab (Avastin) and Erlotinib (Tarceva) After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma Dallas, TX USA 11/12/2010
Details Bevacizumab (Avastin) and Erlotinib (Tarceva) After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma San Antonio, TX USA 11/12/2010
Details Bevacizumab (Avastin) and Erlotinib (Tarceva) After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma Houston, TX USA 11/12/2010
Details Phase I/II Trial of BIBW 2992 in Treating Patients With Recurrent Glioblastoma Multiforme Dallas, TX USA 11/12/2010
Details Cilengitide for Subjects With Newly Diagnosed Glioblastoma Multiforme and Methylated MGMT Gene Promoter - A Multicenter, Open-Label, Controlled Phase III Study, Testing Cilengitide in Combination With Standard Treatment (Temozolomide With Concomitant Radiation Therapy, Followed by Temozolomide Maintenance Therapy) Versus Standard Treatment Alone Dallas, TX USA 11/12/2010
Details RTOG0627 Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme Houston, TX USA 04/13/2010
Details RTOG0627 Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme Galveston, TX USA 04/13/2010
Details RTOG0627 Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme San Antonio, TX USA 04/13/2010
Details RTOG0627 Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme Lubbock, TX USA 04/13/2010
Details 2009-0476: A Phase I dose-finding study of XL184 administered orally in combination with Temozolomide and Radiation Therapy in first line treatment of glioblastoma Houston, TX USA 03/30/2010
Details 2006-0709: Phase I / II Adaptive Randomized Trial of Vorinostat, Isotretinoin and Carboplatin in Adults with Recurrent Glioblastoma Multiforme Houston, TX USA 03/30/2010
Details 2009-0548: A Phase I Study of MK-0752, a Notch Inhibitor, in Patients With recurrent glioma Houston, TX USA 03/30/2010
Details 2009-0597: Randomized Phase II Trial of Standard Dose Bevacizumab Versus Low Dose Bevacizumab plus Lomustine (CCNU) In Adults with Recurrent Glioblastoma Multiforme Houston, TX USA 03/30/2010
Details RTOG 0825 Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab versus Conventional Concurrent Houston, TX USA 03/30/2010
Details BTTC08-01: Phase II Post-RT/TMZ Bevacizumab and Erlotinib for newly GBM without MGMT promoter methylation Houston, TX USA 03/29/2010

Articles on this website which contain the search term:


  (0.9746)   Brain Tumor Treatments: Texas
  (0.7967)   Brain Tumor / Brain Cancer Symptoms, Diagnoses, Treatments and Clinical Trials
  (0.7967)   Noteworthy Treatments For Brain Tumors
  (0.7967)   RSR-13
  (0.7967)   RSR-13
  (0.7967)   Virtualtrials Newsletter
  (0.7967)   Virtualtrials Newsletter
  (0.7967)   Brain Tumor Symptoms
  (0.7967)   RSR-13
  (0.7742)   Temozolomide Update
  (0.7742)   Untitled Document
  (0.7742)   BrainTumor Chat: Dr. Friedman
  (0.7742)   Noteworthy Treatments For Brain Tumors
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Map
  (0.7742)   Treatments
  (0.7742)   Treatments
  (0.7742)   BORON NEUTRON CAPTURE THERAPY (BNCT)
  (0.7742)   Chemosensitivity Testing
  (0.7742)   Doctor / Hospital Address Book
  (0.7742)   Brain Tumor Activism
  (0.7742)   Letter Writing Wizard
  (0.7742)   Brain Tumor Activism





Home | Brain Tumor Guide | Search | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure NovoTTF-100A | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us | Doctors Address Book



Copyright (c) 1993 - 2014 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites